Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Uliledlimab |
Trade Name | |
Synonyms | TJD5|TJ-4309|TJ00-4309|TJ4309|TJ004309 |
Drug Descriptions |
Uliledlimab (TJ004309) is a monoclonal antibody against NT5E (CD73), resulting in activation of an anti-tumor immune response by preventing the conversion of AMP to adenosine in the tumor microenvironment (PMID: 31461341). |
DrugClasses | Adenosine Targeting 23 CD73 Antibody 12 |
CAS Registry Number | NA |
NCIT ID | C159168 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Uliledlimab | Atezolizumab Uliledlimab | 0 | 1 |
Toripalimab-tpzi + Uliledlimab | Toripalimab-tpzi Uliledlimab | 0 | 0 |
Uliledlimab | Uliledlimab | 0 | 1 |